WDNA Fact Sheet: WisdomTree BioRevolution Fund
Share
$20.58
close, Nov 20, 2026
Over the year to Nov 19, 2026, WDNA returned +36.6% in total and charged 0.45% a year.
- 1-year total return
- +33.5%
- to Nov 20, 2026
- Expense ratio
- 0.45%
- a year
- Net flow, 12 months to Jun 30, 2026
- −$358k
- monthly N-PORT basis to Jun 30, 2026
Growth of $10,000, 1 year
WDNA $13,661 +36.6% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.
Returns
WindowTotal return
1 month−12.5%
3 months−13.0%
Year to date+21.9%
1 year+33.5%
3 years+44.9%
5 years−11.8%
Total return, distributions reinvested, each window to Nov 20, 2026.
Ten largest positions
HoldingWeight
TWIST BIOSCIENCE CORP5.95%
MODERNA INC4.14%
ELI LILLY & COMPANY4.08%
JOHNSON & JOHNSON2.97%
UNITED THERAPEUTICS CORP2.45%
NATERA INC2.32%
TEMPUS AI INC2.28%
IMMUNOME INC2.26%
STRUCTURE THERAPEUTICS INC2.12%
STOKE THERAPEUTICS INC2.09%
WDNA top ten by weight, 30.7% of the fund, of its 80 equity positions, from the holdings filed for Jun 30, 2026.
Facts
Holds 80 stocks in healthcare innovation and GLP-1, 26% of its weight in S&P 500 companies · First traded Jun 3, 2021 · Benchmark Its own holdings, as of Jun 30, 2026